Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.96 |
| ▸ | RAB9A | P51151 | 6/20 | 0.96 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.96 |
| ▸ | MAPT | P10636 | 6/20 | 0.63 |
| ▸ | NPC1 | O15118 | 5/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.63 |
| ▸ | LTA4H | P09960 | 5/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.63 |
| ▸ | MEN1 | O00255 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.63 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.63 |
| ▸ | RELA | Q04206 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.63 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | AR | P10275 | 2/20 | 0.56 |
| ▸ | ATP4A | P20648 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL128793 | 0.98 | ALDH1A1 (1.00) | ALDH1A1RAB9AALOX5MAPTNPC1 | |
| SCHEMBL29653953 | 0.89 | ALDH1A1 (0.83) | ALDH1A1RAB9AALOX5MAPTNPC1 | |
| SCHEMBL1771825 | 0.87 | ALDH1A1 (0.79) | ALDH1A1RAB9AALOX5MAPTNPC1 | |
| SCHEMBL23610361 | 0.85 | ALDH1A1 (0.83) | ALDH1A1RAB9AALOX5MAPTNPC1 | |
| Iodide SCHEMBL6175053 | 0.83 | ALDH1A1 (0.68) | ALDH1A1RAB9AALOX5MAPTNPC1 | |
| SCHEMBL172279 | 0.81 | ALDH1A1 (0.70) | ALDH1A1RAB9AALOX5MAPTNPC1 | |
| SCHEMBL8864223 | 0.80 | RAB9A (0.69) | ALDH1A1RAB9AALOX5MAPTNPC1 | |
| SCHEMBL3761118 | 0.78 | RAB9A (0.66) | ALDH1A1RAB9AALOX5MAPTNPC1 | |
| SCHEMBL231094 | 0.78 | LTA4H (0.80) | ALDH1A1RAB9AALOX5MAPTNPC1 | |
| SCHEMBL15829173 | 0.78 | ALDH1A1 (0.66) | ALDH1A1RAB9AALOX5MAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0540143-B1 | Compounds and methods for inhibition of HIV and related viruses | MEDIVIR AB (SE) | 2003-02-05 | — | — | EP | disclosed |
| US-5714503-A | Compounds and methods for inhibition of HIV and related viruses | MEDIVIR AB (SE) | 1998-02-03 | — | — | US | disclosed |
| US-5658907-A | THIOUREA VIRICIDES | MEDIVIR A/B (SE) | 1997-08-19 | — | — | US | disclosed |
| US-5593993-A | VIRICIDES FOR HTLV TREATMENT OF AIDS | MEDIVIR AB (SE) | 1997-01-14 | — | — | US | disclosed |
| EP-0540143-A2 | Compounds and methods for inhibition of HIV and related viruses | Medivir Aktiebolag (SE) | 1993-05-05 | — | — | EP | disclosed |
| WO-1993003022-A1 | COMPOUNDS AND METHODS FOR INHIBITION OF HIV AND RELATED VIRUSES | MEDIVIR AB (SE) | 1993-02-18 | — | — | WO | disclosed |